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ABSTRACT 
Stuart Morton 
 
 
EARLY DETECTION OF OVARIAN CANCER USING GABOR WAVELET 
PHASE QUANTIZATION AND BINARY CODING 
 
 
Ovarian cancer is the 5
th
 most common cancer in women, but it is the most 
difficult to detect in its early stages. Early detection and treatment of ovarian 
cancer has been shown to increase the five year survival rate of a woman from 
12% if caught in stage four of the disease up to 92% if caught in stage one of the 
disease.  Using signal processing, pattern classification and a learning algorithm, it 
is possible to identify patterns in high dimensionality mass spectrometry data that 
distinguishes between cancer and non-cancer ovarian samples.  For our research, 
proteomic spectra were generated using SELDI-TOF mass spectrum data, which 
was composed of 162 ovarian cancer and 91 non-ovarian cancer samples.  We 
introduce a Gabor filter on the mass spectrometry data and design a binary coding 
scheme for phase quantization encoding that is used for the pattern classification.  
This pattern will expose crucial features in the data that can be used to correctly 
classify unmasked samples for the presence or absence of ovarian cancer.  Our 
proposed algorithm was able to successfully discriminate ovarian cancer and non-
ovarian samples that yielded results with sensitivities, specificities and accuracies 
in the 90% to 100% range. 
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CHAPTER ONE: INTRODUCTION 
Introduction to Subject 
Data published by the American Cancer Society has shown that approximately 1.4 
percent of women in the United States will develop ovarian cancer during their 
lifetime (Fergus 2000b).  This percentage is equivalent to about 22,500 new cases 
of ovarian cancer each year in the United States, which resulted in approximately 
15,000 deaths in 2006 (NOCC 2006).  As with other types of cancer, ovarian 
cancer is the result of excessive growth of some cells in the epithelial layer that 
surrounds the ovaries.  The cancer can then spread to other parts of the body via 
the bloodstream or lymphatic system, via a process called shedding, which 
involves ovarian cancer cells that break away and spread to other tissues or 
organs.    
Ovarian cancer has four defines stages: I, II, III and IV, each of which has three 
sub stages except for stage IV.  Stage I involves the growth of the cancer that is 
limited to the ovary or ovaries; Stage II is the growth of the cancer in one or both 
of the ovaries with an extension into other pelvic organs; Stage III has growth one 
or both of the ovaries and either the cancer has spread to the lining of the abdomen 
or to the lymph nodes; Stage IV is the most advanced stage of ovarian cancer with 
growth in one or both of the ovaries and distant metastases, which is growth 
outside of the peritoneal cavity (NOCC 2006).   
During the last ten years, scientists have discovered two genes that greatly 
increase a woman‟s chances of developing ovarian cancer.  These genes are 
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BRCA1 (Breast Cancer 1), and BRCA2 (Breast Cancer 2).  It is believed that 
these genes were tumor suppressor genes, but scientists now believe that these two 
genes are involved with the mismatch repair functionality in genes (Fergus 
2000a). The mismatch repair function corrects mistakes in DNA, which can cause 
a gene to stop producing a protein, or even prevent that protein from functioning 
properly.  When either of these two genes is mutated, the normal functionality of 
BRCA1 or BRCA2 is reduced, and thus cannot prevent a cell from becoming 
cancerous. 
Ovarian cancer is not the most common cancer among women, but it has 
proven to be the most difficult to detect.  When the ovarian cancer is detected in 
Stage I and treated, the five year survival rate can be as high as 92.1%.  If it is 
detected in Stage IV and treated, the five year survival rate is as low as 11.6% 
(Unknown 2002). There are three main methods that are used today to screen for 
ovarian cancer: Pelvic/rectal examination, ultrasound and the CA-125 blood test.  
These tests are not consistently reliable, or accurate in screening for ovarian 
cancer, and they are very poor in determining ovarian cancer in the early stages of 
the disease.  The pelvic/rectal exam involves the physician feeling the uterus and 
ovaries to find any abnormalities in their shape or size (NOCC 2006).  An 
ultrasound uses sound waves to create pictures of the ovaries to determine if the 
tissue is healthy, or contains fluid-filled cysts, or has tumors.  The CA-125 blood 
test detects the levels of the CA-125 cancer antigen protein levels in the 
bloodstream.  When a woman has ovarian cancer, the amount of CA-125 tends to 
rise above 35 u/ml.  This is not a definitive test, because non-cancer patients can 
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test positive to this test, and cancer patients may not produce enough CA-125 to 
produce a positive response to the test (Unknown 2002). 
“Mass spectrometry (MS) is a powerful tool for determining the masses of 
biomolecules and biomolecular fragments present in a complex sample mixture.” 
(Lilien 2003)  A mass spectrum is created using a mass spectrometer, which is 
composed of three components: ionizer, mass analyzer and the ion detector (Yates 
2000).  The ionizer converts the molecules of a sample into ions by using a laser 
to excite the molecules into a gaseous phase.  These excited molecules are 
separated by passing through a magnetic field until they collide with an ion 
detector.  The mass spectrometer determines the mass to charge ratio for the 
molecule based upon the electric current that is generated when the molecule 
strikes the ion detector along with the time of flight from the ionizer to the 
detector.  The result of the mass spectrometer is a set of mass to charge (m/z) 
values that match up with relative intensities based upon the number of molecules 
that strike the detector with a particular m/z value. When a mass spectrum is 
relatively small, a visual inspection can be used, but as the number of protein 
fragments in the sample increases, it is necessary to utilize algorithms to detect the 
presence or lack of presence of particular molecules in a sample. 
 Many techniques have been proposed to deal with detection of cancer from 
high dimensional of mass spectrum data.  These include biomarker detection, 
decision trees, peak detection, and principle component analysis.  In the proposed 
algorithm, we utilize Gabor filters, which have the  
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“… advantage of (1) maximizing joint localization in both spatial and 
frequency domains; (2) flexibility; [Gabor functions] can be freely tuned to a 
continuum of spatial positions, frequencies and orientations, using arbitrary 
bandwidths….” (O. Nestares 1998) 
The Gabor filters transform a mass spectrum data matrix of size n-by-m into a 
matrix of n-by-(m- (2 * filter size)) where each value in the matrix is a complex 
number that falls into one of the four phases of a Cartesian coordinate system.  In 
the proposed algorithm, the phases are quantized and coded to identify the 
quadrant where the coefficient a + bi from the output matrix resides.  Using the 
coded values, a two-bit encoding scheme creates a binary string that represents the 
characteristics of that patient (ovarian cancer positive or negative).  By combining 
all of the binary coded strings of the ovarian cancer patients into one pattern using 
a voting scheme with a threshold criterion, it is possible to predict blinded testing 
samples for ovarian cancer.  In a similar manner, the control samples will be 
combined to create the overall pattern that is indicative for ovarian cancer 
negative patients.   
Importance of Subject 
As described above, the ability to predict ovarian cancer while in Stage I 
of the disease is critical to ensure the highest five year survival rate.  Current 
screening techniques (Pelvic/rectal examination, ultrasound and the CA-125 blood 
test) have proven to be very ineffective in detecting ovarian cancer during its early 
stages.  For example, the CA125 test is only able to predict 40 to 50% of early 
ovarian cancers (Check 2002).  The actual incidence of ovarian cancer in the 
typical population is very low, only 40 to 50 cases per 100,000 women.  With this 
in mind, it is easy to see that any effective detection technique must minimize the 
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number of false positives.  In addition, the technique must be able to correctly 
identify the benign samples with a similar effective rate.  Dr. Steven Skates, a 
biostatistician at Massachusetts General Hospital and assistant professor of 
medicine at Harvard Medical School, has determined that to achieve the low rate 
of false positives and false negatives, the specificity of the technique must exceed 
99.6% and the sensitivity must exceed 98% (Check 2002).  The proposed 
algorithm will shown that it can meet these two criteria by tuning the frequency 
and variance of the Gabor filter along with the threshold value used in the voting 
scheme for coding the ovarian cancer and control pattern binary codes. 
It is important to note that in order to discover ovarian cancer in women in 
Stage I, it will require both doctors and women to be very diligent in testing on a 
regular basis.  This testing should include women who have family history of 
ovarian cancer, and women who do not have any family history of ovarian cancer.  
With the amount of testing necessary to cover the women who are at risk for 
ovarian cancer, it is critical to produce a test that is both cost and efficient in 
predicting the disease.   In addition, it is important to utilize a test that provides a 
sample to the lab with the least amount in invasiveness for the women, so that that 
individual will not be reluctant to return for testing in future years.  Our testing 
uses blood samples, which many would agree is more pleasant than a pelvic exam. 
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CHAPTER TWO:  BACKGROUND 
Detection Algorithms for Mass Spectrometry 
This section of the literature review will discuss some the existing 
techniques being used to analyze mass spectrum data.  In order to identify whether 
a sample of ovarian tissue tests positive for cancer, there needs to be an 
identifying characteristic in the mass spectrometry data that differentiates the 
sample.  One of the major hurdles in mass spectrometry at this time is the ability 
to handle large numbers of protein fragments in a sample, and over the last few 
years, many algorithms have been created to solve this problem.  
The goal of a mass spectrometry classification algorithm is the 
discrimination of one condition from another by analyzing the mass spectra 
(Lilien 2003).  Many types of mass spectrometry classification algorithms 
(MSCAs) have been developed to detect disease in humans, as well as observe the 
changes in those diseases (Austen 2000), (Petricoin 2002), (Paweletz 2000) and 
(Ball 2002).   An MCSA can be categorized by the following items: type of mass 
spectrometry data, type of algorithm used on the MS data, and the method for 
classification verification.   
The type of mass spectrometry data used in an experiment can be broken 
down into three components: completeness of the spectrum, manual preprocessing 
and the source of the sample.  If the entire mass spectra are used, which means 
that all of the m/z values from zero to the upper detectable boundary, then the data 
sets are considered to be complete spectra, otherwise it is labeled as a partial 
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spectra.  When the spectra are normalized or if sections of the spectrum have been 
removed, then the data has been preprocessed.  In most cases this is true due to the 
introduction of noise and inconsistencies of samples by the same piece of MS 
equipment.  Finally, the type of data set used in an experiment can be the result of 
simple of complex fragments.  Again, the majority of the research into MSCAs 
has utilized complex fragments that result in tens of thousands of peaks. 
  In terms of the types of algorithms used for classification of mass 
spectrometry data, there are two main types: heuristic and exact classifications.  A 
heuristic algorithm goes through multiple iterations until it converges on a 
classifier.  Examples of this type are genetic algorithms, neural networks and 
simulated annealing.  On the other hand, exact classification algorithms are “… 
computationally efficient; they are noniterative and deterministic (i.e., always 
compute the same solution.) (Lilien 2003).” Some examples of an exact 
classification are linear discriminant analysis, principal component analysis 
(PCA), and the Gabor phase quantization algorithm introduced in this paper. 
Finally, the method of classification for the algorithm must be confirmed 
in order to determine the effectiveness of the algorithm to detect future unknown 
samples.  A technique called the leave-out experiment involves splitting the data 
set into training set and a testing set and repeating that process multiple times. In 
some cases, one of the split data sets will perform better than the others, and it is 
important to note that difference in your report.  When the testing set contains 
only one or very few samples, it is considered to be partial.   The following 
paragraphs describe specific examples of MSCAs.  
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(Lilien 2003) used principal component analysis (PCA) to reduce the 
dimensionality of the feature set followed by a linear discriminant analysis (LDA) 
to project the spectrum onto a surface.  This projected surface is then used as the 
criterion for classification for the test data, which is also dimensionally reduced 
using PCA and then projected onto a surface using the LDA.  Using a 
classification confidence, the sample is either classified as healthy or diseased. 
 Unlike PCA, which is an unsupervised pattern recognition technique that 
tends to lose resolution of spectra between proteins as the data set increases in 
size, (Wagner 2002) was able to show that the use of a supervised learning 
technique version of PCA called discriminant principal component analysis 
(DPCA) along with linear discriminant analysis (LDA) could effectively 
discriminate static time-of-flight secondary ion mass spectrometry data.  In 
addition, they were able to limit the number of misclassifications of the spectral 
data using just the LDA when compared to the use of either PCA or DPCA on the 
same data set. 
(Li 2002) used a ranking algorithm to determine a large number of peaks 
in the mass spectrometry data of breast cancer patients that could identify 
biomarkers according to two diagnostic groups.  They determined that there were 
three top peaks that could be used for biomarkers for breast cancer (BC1, BC2 and 
BC3).  Using multivariate regression, the three biomarkers were combined into a 
single composite index.  Using a boot-strap cross validation, they were able to 
improve the diagnostic power (area under the curve) for the single composite as 
compared with the individual biomarkers.  
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Another group, (Yasui 2003), used SELDI-TOF equipment to create high 
dimensionality mass spectrometry data.  Their research was two-fold: (1) separate 
protein signals from the background noise of the intensity signal to identify 
biomarkers to discriminate prostrate samples form control samples and (2) 
calibrate the protein mass/charge measurements across samples.  The latter object 
is an issue that we addressed in our research, which is the reason why we used the 
smoothing technique to minimize the fluctuation of the mass spectrometry data 
from sample to sample. 
(Petricoin 2002) used ovarian cancer mass spectrometry data that 
contained about 15,200 mass to charge values.  Using a genetic algorithm and 
cluster analysis, they created a pattern of about five to twenty key proteins in their 
training model to differentiate the cancer and non-cancer samples.  Using this 
model, they performed the same genetic algorithm and cluster analysis on a test 
sample in order to verify the model.  The results of this model were 100% 
sensitivity, 95% specificity, and a positive predictive value of 94%, which is much 
higher than the 35% predictive value of the CA-125 blood test. 
Utilizing decision trees and a boosting algorithm, (Qu 2002) and (Wagner 
2002) were able to effectively use SELDI mass spectrometry data to differentiate  
prostrate cancer samples from noncancer samples.   Traditionally, learning 
algorithms are susceptible to overfitting, which means that the algorithm works 
well for that particular set of data, but when it is used on a new data set it fails to 
predict the cancer form the noncancer samples.  By using boosting, they were able 
to increase the minimize margin, so that the chances of misclassifying the test 
samples were decreased. 
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 In (Wang 2004) they used mass spectrometry to analyze a three marker 
panel of transthyretin, full-length apolopoprotein A1, and an internal fragment of 
inter-α-trypsin inhibitor chain 4 (ITIH4).  The purpose of their study was to show 
that the use of mass spectrometry immunoassay would be more effective in 
distinguishing modified forms of proteins then the traditional immunoassays.  
Using a 96-well filter plate to prepare the three markers, they sent the samples 
through a mass spectrometer for each of the three proteins.  The experiment 
showed that the mass spectrometry immunoassay was able to simultaneously 
quantify and distinguish multiple forms of the transthyretin, as well as identify the 
single peak of the ITIH4 along with the smaller peptides. 
A slightly different approach was taken by (Wu 2003) to analyze mass 
spectrometry data.  Instead of using one type of classification algorithm, they 
decided to analyze four different types of algorithms: bagging, arc-fs, arc-x4, and 
random forest.  The bagging algorithm involves creating classification trees by 
recursively splitting subsets of the data until a terminal node has been reached, 
which is labeled as a final classifier.  Both arc-fs and arc-x4 utilize the concept of 
boosting, which is an adaptive re-sampling of the original data, so that the weights 
are increased for the frequently misclassified samples.  Arc-fs uses a weighted 
voting scheme, while the arc-x4 uses a un-weighted voting scheme.  Finally, the 
random forest blends two machine learning mechanisms: bagging and random 
feature selection, which increases the predictive accuracy.  After running each of 
the algorithms, they discovered that the random forest technique provided the 
lowest misclassification as well as a more stable assessment of the errors in the 
classification. 
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Gabor Filters 
This section describes the use of Gabor filters to detect patterns in two or 
three dimensional images that can be used to discriminate one image from another 
image.  Mass spectrometry data produces a signal that can be graphed into a two-
dimensional image on an X-axis (mass to charge values), and on the Y-axis 
(intensity).  This signal provides an excellent opportunity to make use of Gabor 
filters, which can extract spatially localized spectral features (Prasad 2005). Gabor 
filters are created using a one dimensional sinusoid that is modulated with a 
Gaussian, which is a symmetrical frequency distribution that has a precise 
mathematical formula that is related to the mean and standard deviation of the 
sample (Caldwell 2006).  One dimensional Gabor filters are calculated using a 
variance of the Gaussian and a frequency, while two dimensional Gabor filters use 
the variance of Gaussian, frequency and orientation.   
Gabor filters have been used for image processing, such as image coding 
and compression, and analysis of texture.  (O. Nestares 1998) propose an 
optimized solution for spatial implementation of the Gabor scheme.  This 
optimized solution allows for an improvement in the quality of image 
reconstruction, so that the reconstructed images are visually indistinguishable 
form the original image. 
 (Daugman 2004) proposes the use of a two dimensional Gabor filter for 
iris pattern recognition.  Unlike the face, which has a variety of expressions, the 
iris is more consistent and varies greatly between individuals, and the iris is not 
sensitive to the angle of the illumination to produce a high quality image.  Each 
iris pattern is demodulated to extract the phase information using the two-
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dimensional Gabor filter.  The phases are coded to identify the location of a given 
area of the iris by using a binary system ((1,1), (1,0), (0,1) and (0,0)).  This 
process was repeated until 2048 bits were obtained.  Irises of two different 
individuals were compared by sending the 2048 bits into the Hamming distance 
formula, which calculates the number of differences that exist between two binary 
numbers.  The ability to decide if two irises were from the same individual was 
achieved by having the smallest Hamming distance value.  In fact, 50% of the 
image comparisons between the same irises had a Hamming distance of zero, and 
an average hamming distance of 0.019. 
 (Lepistö 2003) used Gabor filters to discriminate textures and color in 
images.  Their algorithm used multi-resolution Gabor filters to be applied to a hue, 
saturation and intensity channels (HSI) color space.  The Gabor filters were 
applied to each color channel separately to create a feature vector, which was then 
combined with the other color channels into one vector that was used for 
classification based upon the k-nearest neighbor. 
Research Hypotheses 
Detecting ovarian cancer in its earliest stages is critical to the five year 
survival rate of women who are positively diagnosed with the disease.  Current 
detection methods have fallen short in effectively revealing ovarian cancer while 
it is still in Stage I or Stage II. 
 
Hypothesis: 
H1: Using a one-dimensional Gabor filter along with a binary coding scheme, 
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it will be possible to detect ovarian cancer with a sensitivity and specificity 
rate greater than 90%. 
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CHAPTER THREE: METHODOLOGY 
Software 
The mass spectrum data used in this research was stored in two sets of 
Excel™ files: one for the ovarian cancer samples and one for the control samples 
were retrieved from the medical school at Northwestern University in Chicago, 
IL.  Each file contained two columns that contained the mass to charge values and 
the corresponding intensity value.  Using a script written for Matlab™, the 
intensity values for all of the ovarian cancer samples for mass to charge values 
between 500 to 11,000 m/z were extracted into training and testing data files.  The 
same procedure was used to create the testing and training data files for the 
control samples.  Matlab™ was also used to run a script file that process and 
analyze the data files.  The Matlab™ related script files can be found in Appendix 
A and Appendix B. 
Background 
SELDI-TOF Mass Spectrometry 
 
The ovarian cancer data was collected from patients’ serum samples and 
their mass spectrum was generated by using Surface-Enhanced Laser Desorption 
and Ionization - Time of Flight (SELDI-TOF) instrument.  The SELDI-TOF uses 
a protein chip array whose surface acquires proteins with the help of special 
protein docking sites that are either biologically or chemically created.  After the 
chip has been created and washed, the desired sample is crystallized with energy 
absorbing molecules that serve to absorb the energy from the laser and ionize the 
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protein (Yasui 2003).  Each protein fragment will then fly through the flight tube 
to the detector at the other end based upon the molecular weight of the protein and 
its associated charge.  When the protein fragment reaches the detector, the 
intensity at that instant in time is recorded into a data pair along with the mass and 
the charge for that protein.  The ovarian and control sample data produced over 
48,000 unique data pairs over the mass/charge range of 0 – 30,000.  For our 
analysis, we used the mass/charge ratios of 500 to 11,000, which gave us over 
17,500 data points. These data points were utilized in our algorithm for classifying 
ovarian versus non-ovarian cancer samples. Figure 1  illustrates the SELDI-TOF 
process. 
+ +-+
-
Flight Tube
Detector
Mass/Charge (M/Z)
Protein Chip Array
Laser
 
Figure 1: SELDI-TOF Process 
Gabor Wavelets and Phase Quantization 
   
Gabor filters have been used for image processing, such as image coding and 
compression, and analysis of texture (Daugman 2004).  (O. Nestares 1998) 
proposed an optimized solution for spatial implementation using a Gabor scheme.  
This optimized solution allows for an improvement in the quality of image 
reconstruction, so that the reconstructed images are visually indistinguishable 
form the original image.  Gabor filters have been shown to respond to optimal 
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localization properties in the spatial and frequency domains, which is shown in 
Figure 2 from (Prasad 2005) . 
 
Figure 2: Gabor filter composition for 1D signals: (a) sinusoid, (b) a Gaussian 
kernel, (c) the corresponding Gabor filter. 
 
In this paper, a Gabor filter bank is created using a one dimensional 
sinusoid that is modulated with a Gaussian, which is a symmetrical frequency 
distribution that has a precise mathematical formula that is related to the mean and 
standard deviation of the sample (Caldwell 2006).   For 1D mass spectrum 
analysis, we applied the one dimensional Gabor filter bank, which requires four 
parameters including (i) an n-by-m matrix for n observations and m features, (ii) 
variance along the x and y-axes respectively, (iii) center frequencies along the x 
and y-axes respectively, and (iv) the size of filter.  Equation 1 shows the 1-D 
Gabor wavelet is: 
ωπjσ
x
x
x ee
σπ
σωxG x
)
2
(
2
2
2
1
),,(

  (1) 
 
 
where x  is variance,  is frequency.  In order to determine the most effective 
combination, we used multiple combinations of the variance and the frequency (5 
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and 5, 5 and 10, 10 and 5, 10 and 10 respectively) to construct filter bank.   The 
output vector after Gabor convolution is a matrix of size n by (m–(2*filter size)).  
Each Gabor coefficient after the convolution is a complex number and it falls into 
one of the four phases in Cartesian coordinate system.  These phases are quantized 
and coded to identify the quadrant where the coefficient a + bi resides, which is 
shown in Figure 3. 
 
Figure 3: Four Phase Quantization Diagram 
 
The two-bit encoding scheme used in the algorithm is based on the signs of real 
part and imagery part of Gabor coefficient, such as (sgn(a), sgn(b)) where 






0   ,0
0   ,1
)sgn(
x
x
x  (2) 
i.e. the real and imaginary part of coefficients can be represented by one of four 
quadrants: (1,1), (1,0), (0,1) and (0,0) as shown in Figure 3.  For example, a 
spectrum vector (3.2-0.2 i, -5.0 + 0.7 i, -4.6 -8.5i, …) can be converted to a binary 
string of (10, 01, 00, …).   
  
Real 
Imaginary 
+ 
+  
 
(1,1) 
(1,0) 
(0,1) 
(0,0) 
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Hamming Distance 
 
Hamming distance is defined to be the “distance between binary datawords 
c1 and c2, denoted by d(c1,c2) to be the minimum number of bits that must be 
"flipped" to go from one word to the other (Johnson 2003).”    When a dataword is 
transferred over a medium errors occur and the dataword that is received on the 
other end is different than the original dataword.   By using the minimal Hamming 
distance, it is possible to create a dataword that closely resembles the original 
dataword (Bhatti 1995).  For example, if the original dataword was 11000, but the 
received dataword was 11001, then the minimal Hamming distance would be one.  
In this case, the last one would be flipped to become a zero, and then the original 
dataword is recreated.  We use Hamming distance to determine how closely a 
testing sample reflects the binary code of the two types of training codes (cancer 
and control).  If the Hamming distance between the test sample and the training 
cancer binary code is smaller when compared to the Hamming distance of the test 
sample and the training control binary code, the sample is labeled as cancer 
positive.  The test sample would be labeled as cancer negative if the opposite is 
true. 
Procedures  
The data used in this project was provided by the National Ovarian Cancer 
Early Detection Program (NOCEDP) clinic at Northwestern University Hospital 
in Chicago, IL.  A total of 253 samples consisting of 162 with ovarian cancer and 
91 normal samples were provided with a feature set of well over 13,500 peaks 
after the first 2000 peaks were truncated.  This truncation was due to the low M/Z 
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values, and the fact that the ‘energy-absorbing-molecules’ used in the creation of 
mass spectrometry data distort the intensity of the proteins below the 2000 peak 
level (Yasui 2003).  For this project, we used a subset of the ovarian (120 patients) 
and normal (65 patients) data samples during the first run in order to get a sense of 
the effectiveness of our algorithm.  Figure 4 shows the gel views of both cancel 
and normal serum samples. 
Cancer
Normal
 
Figure 4: Gel view of cancer and normal serum samples 
 
The data set from the mass spectrometry data was split into two parts: a 
training set and a testing set.  The training set for the ovarian cancer group used 
2/3 of the original ovarian cancer samples, and the control group used 2/3 of the 
original non-ovarian cancer samples.  For the testing set for the ovarian cancer 
group, we used the remaining 1/3 of the original ovarian cancer samples, and the 
testing control group used the remaining 1/3 of the original non-ovarian cancer 
samples.  It should be noted that the ovarian cancer data and the control group 
(non-ovarian cancer) data were not mixed in this study, because we wanted to 
create a pattern that would indicate just ovarian cancer or non-ovarian cancer.  In 
order to prevent overfitting, the original data set was split in a similar manner two 
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more times using different combinations of the ovarian cancer samples and the 
control samples. 
After the data set was split into two sets, the data was preprocessed using a 
baselining technique and a smoothing function to remove some of the noise from 
the data.  The data was baselined using baseline subtraction, which is calculated 
using a window size of 128 points and three functions.  The functions in order are 
min, mean and median, which resulted in the finalized baselined data.  In addition 
to the baselining, we used a smoothing function that is the overlapping averaging 
on the range to each data point with a window size again of 128 data points.  The 
preprocessing of the data was executed on both the training and testing sets. 
Figure 5 illustrates the spectra with (b) and without (a) baseline subtraction 
process. 
 
Figure 5: (a) Before and (b) After baseline subtraction 
 
 
(a) (b) 
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Following the preprocessing of the data, we applied a 1-D Gabor filter 
with different combinations of the frequency and variance to produce the phase 
data.  At this point in our algorithm, we need to create a code from the output 
phase data for the training ovarian samples and another code for the training 
control samples, which will be used to determine if a sample is ovarian cancer 
positive or negative.  As we have described above, the output of the 1-D Gabor 
filter will be a real number along with an imaginary number, each of which will 
have either a positive or negative sign.  Based upon the sign of the each 
component, we assign a value of one or zero as described above in Equation 2.  
This process continues for each feature in the training cancer sample, which 
results in a matrix of binary strings. In order to generate a coded binary pattern 
that is indicative of a positive cancer sample, we use a voting scheme to evaluate 
the consistency of the bits with in the same column of the sample. The voting 
scheme is based upon a threshold.  When the number of ones in a column exceeds 
the threshold, that column is labeled as a one, and the same is true when the 
number of zeroes in a column exceeds the threshold.   If neither the number of 
ones nor zeroes exceeds the threshold, then the column is marked as indeterminate 
(x). In the program, the number of zeroes was checked first to see if it exceeded 
the threshold value, and then the number of ones was tested.  To ensure that this 
did not bias towards zero when the threshold value was small (<30%), the 
program was modified to examine the ones first and then the zeroes.  With this 
modification, the results were the same. After the cancer samples in the training 
set have been evaluated, the non-cancer (control) training samples are processed 
in the same manner.  Table 1 provides an example using a threshold of 80%. 
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Table 1: Pattern calculation example 
 
   
Sample           
    # 
Feature 
#1 
Feature 
#2 
Feature 
#3 
Feature 
#4 
Feature 
#5 
        
Feature 
#6 
1 1 0 1 1 0 1 
2 1 1 0 0 0 1 
3 0 0 1 1 0 0 
4 1 0 1 1 0 0 
5 1 0 0 1 1 1 
       
  Result 1 0 x 1 0 
                  
    x 
 
     Once the patterns have been created for both the ovarian cancer samples and 
the non-ovarian cancer samples in the training set, the next step is to process the 
testing set in a similar manner to the training set.  The samples will again use the 
1-D Gabor filter, and then the output will be coded with either be a zero, one or a 
symbol x to create a binary string for that sample.   
At this point, the testing set will processing will diverge from the training set.  
Each coded binary string in the testing set was individually compared against the 
coded patterns created for the ovarian cancer and non-ovarian cancer training 
samples.  A coded binary string can be considered to represent the cluster of 
cancer samples or the cluster of control samples. In order to determine if an 
unknown test sample belongs to one cluster or the other, a measurement must be 
performed to determine if the test sample lies closer to the cancer or control 
cluster. To make this determination, we used the Hamming distance.  The 
Hamming distance, which is defined as the number of differences of symbols 
between two string inputs, was used to compare the two binary strings.  If the 
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Hamming distance of the testing string and the ovarian training string was smaller 
than the Hamming distance of the testing string and the non-ovarian training 
string, then that testing string was labeled a positive for ovarian cancer.  The 
testing sample was a labeled negative if the opposite was true.  When all of the 
testing set (ovarian and control) was evaluated, the sensitivity, specificity and 
accuracy measurements were calculated to determine the effectiveness of our 
coded pattern algorithm.  Figure 6 summarizes the overall process for serum 
protein profiling analysis based on mass spectrum data sets.  
Mass SpectraSerum Proteins
Cancer Group 
Binary  Strings
Normal Group 
Binary Strings
Voting Scheme
Consensus String 
(Cancer)
Consensus String 
(Normal)
Unknown
Sample
Cancer Prediction
Cancer & Normal 
Samples
Protein Chip &
Mass Spectroscopy
Gabor Wavelet 
Coefficients 
Convolution 
Binary Encoding
Hamming Distance
Gabor Filter Bank
Phase Quantization
 
Figure 6: System Architecture for Serum Protein Profiling Analysis 
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Analysis 
The analysis of the results from the serum protein profiling algorithm involved 
using the technique of a confusion matrix, which is described in the following 
section. 
A confusion matrix contains information about actual and predicted 
classifications that are generated by a classification system. In the confusion 
matrix, there are four possible outcomes: true positive (TP), false negative (FN), 
false positive and true negative (TN).  True positive and a true negative are 
obviously correct predictions. The false positive is the result of predicting an 
outcome as positive when it is in fact negative, and a false negative is a negative 
prediction when the actual result is positive.  These values are described in Figure 
7. 
True Negative (TN)False Positive (FP)
Class Negative
(ex: disease absent)
False Negative (FN)True Positive (TP)
Class Positive
(ex: disease present)
Prediction negative 
(ex: test negative)
Prediction Positive 
(ex: test positive)
 
Figure 7: Confusion Matrix 
 
Sensitivity, which is the number of patients with disease that have a positive 
test result, is calculated as TP/(TP + FN).  Specificity is defined as the number of 
patients who do not have disease that have a negative test result is calculated as 
TN/(TN + FP).  Finally, accuracy of successfully predicting both the patients with 
disease and those without disease is calculated as (TP + TN)/(TP +TN + FP +FN).  
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For any algorithm, acquiring 100% accuracy is very difficult to achieve, but the 
number of false positives and false negatives must be minimized.  As Figure 8 
from (Tape) indicates, the overlap of normal and diseased patients produces a 
number of false positive and false negative results for any particular criteria 
shown as the black line in the figure.  As the black line is moved to the right, the 
number of false positives is reduced, but the number of false negatives is 
increased.  If the black line is moved to the left, then the number of false positives 
increase, and the number of false negatives decreases.  For ovarian cancer 
screening, it is important to weigh the effect of telling someone that they are 
positive for cancer and must seek treatment when it is not needed, or informing 
someone that they are negative for the disease when in fact the test is not correct. 
 
Figure 8: Example of Diagnostic Results 
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CHAPTER FOUR: RESULTS 
The results are reported in three main sections. The first section presents 
the results from the first data set combination, the second section presents the 
results from the second data set combination, and the last section presents the third 
data set combination.  
Data Set One 
As stated above, multiple combinations of variance and frequency for the 1-D 
Gabor filter were used to determine which combination produced the best results 
for the first pass of the data using 120 ovarian cancer samples and 65 control 
samples as shown in Table 2. 
Table 2: Data Set One Results 
 
Configuration Sensitivity Specificity Accuracy 
Variance = 5 
Frequency= 5 
97% 92% 95% 
Variance = 5 
Frequency= 10 
95% 100% 97% 
Variance = 10 
Frequency= 5 
97% 96% 97% 
Variance = 10 
Frequency= 10 
100% 100% 100% 
 
As we can see from this table, the best results were a result of using a variance of 
10 and a center frequency of 10.  Missing from the previous table is the fact that 
we initially used a threshold value of 85% to determine the code pattern from the 
ovarian cancer and the non-ovarian cancer samples in the training set.  With this 
in mind, we wanted to see if different threshold values for determining the coded 
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pattern would affect the results from the best entry in Table 2.  The values of the 
threshold ranged from 50% to 90%, and the sensitivity, specificity and the 
accuracy values were calculated and are shown in Table 3. 
Table 3: Threshold Comparison for Data Set One 
 
Threshold Accuracy Sensitivity Specificity 
50% 95% 66% 82% 
60% 96% 72% 86% 
65% 87% 96% 74% 
70% 96% 85% 92% 
75% 94% 100% 83% 
80% 100% 86% 95% 
85% 100% 100% 100% 
90% 100% 100% 100% 
 
Looking at the table, you can see that the threshold value of 85% maximizes all of 
the criteria that we have been using to determine the effectiveness of our coded 
pattern algorithm along with the variance of 10 and the frequency of 10 for the 1-
D Gabor filter.  Beyond the 85% threshold, the sensitivity, specificity and 
accuracy have the same values as those at a threshold of 85%.  The standard 
deviation (SD) values for the sensitivity, specificity and accuracy for data set 
combination one are shown in Table 4. 
Table 4: Standard Deviation for Data Set One 
 
 Sensitivity Specificity Accuracy 
Standard Deviation (SD) 2.06 3.86 2.06 
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Data Set Two 
The results from data set combination two are very similar to those of data set 
combination one.  Examining Table 5, it is apparent that the variance/frequency 
combination of 10 and 10 respectively has produced the best results, but in 
contrast to the data set combination one, the variance of 10 and frequency of 5 has 
also produced excellent results.   
Table 5: Data Set Two Results 
 
Configuration Sensitivity Specificity Accuracy 
Variance = 5 
Frequency= 5 
96% 85% 92% 
Variance = 5 
Frequency= 10 
96% 91% 94% 
Variance = 10 
Frequency= 5 
98% 91% 95% 
Variance = 10 
Frequency= 10 
98% 91% 95% 
 
 
Similar to the SD values from data set combination one, the SD values for this set 
are similar for the sensitivity and the accuracy and about 2 times the value for the 
specificity as shown in the following table. 
Table 6: Standard Deviation for Data Set Two 
 
 Sensitivity Specificity Accuracy 
Standard Deviation (SD) 1.15 3.00 1.41 
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Data Set Three 
The results from data set combination three produced slightly different patterns 
than the two previous sets with the variance/frequency combination of 10 and 5 
respectively creating the best results.   
Table 7: Data Set Three Results 
 
Configuration Sensitivity Specificity Accuracy 
Variance = 5 
Frequency= 5 
91% 93% 92% 
Variance = 5 
Frequency= 10 
88% 96% 91% 
Variance = 10 
Frequency= 5 
98% 93% 91% 
Variance = 10 
Frequency= 10 
88% 96% 91% 
 
Standard deviation values for the sensitivity, specificity and accuracy for data set 
combination three are shown in the Table 8.  
Table 8: Standard Deviation for Data Set Three 
 
 Sensitivity Specificity Accuracy 
Standard Deviation (SD) 4.72 1.73 0.5 
 
Overall Findings 
Using all of the combinations of variance and frequency on all three of the data 
sets, the following average sensitivity, specificity and accuracy values were 
calculated along with their corresponding standard deviation values are detailed in 
Table 9. 
 
 
 30 
Table 9: Overall Sensitivity, Specificity and Accuracy Values 
 
 Sensitivity Specificity Accuracy 
All values of         
variance and frequency 
95.17% 92% 94.17% 
Standard Deviation (SD) 4.00 4.23 2.89 
 
 
Using only the variance value of 10 and the frequency value of 10 as inputs for the 
1-D Gabor filter for training sets one, two and three, the following overall results 
were observed. 
Table 10: Overall Results for Variance=10, Frequency=10 
 
 Sensitivity Specificity Accuracy 
      Variance = 10    
      Frequency= 10 
95.33% 95.67% 95.33% 
Standard Deviation (SD) 6.43 4.51 4.51 
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CHAPTER FIVE: DISCUSSION 
This section discusses the results reported in chapter four, which includes the 
explanation of the outcomes from the confusion matrix. 
Explanation of Outcomes 
Our coded pattern algorithm produced highly successful results for determining 
whether a given sample was positive for ovarian cancer.  In the first data set 
combination the results for the sensitivity, specificity and accuracy ranged from 
66% to 100% with the best results being achieved when the Gabor filter used the 
variance value of 10 and the frequency value of 10.  Since this algorithm depends 
on a voting threshold to determine the binary value of each feature column, it is 
important to see if the using the arbitrary threshold of 85% really produced the 
best results for a variance of 10 and a frequency of 10.  As is indicated in Table 3, 
a threshold value of 60% and below produced poor results, while a threshold value 
of 85% and above produced an accuracy of 100%.   
The results were consistent across the other two training/testing sets with 
specificity, sensitivity and accuracy values in the mid to high 90% range.  It is 
worth noting that in data set combination three that the best results for the 
sensitivity (the ability to detect cancer positive samples) were obtained using a 
variance of 10 and a frequency of 5.  The third data set also produced the lowest 
accuracy values out of all three combination data sets, which (Lilien 2003) has 
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reported as a consequence of using a leave-out experiment to validate your 
classification discriminant.  
Looking at the all three data set combinations and all of the combinations of 
variance and frequency, the sensitivity, specificity and the accuracy were 95.17%, 
92% and 94,17% respectively.   This leads one to consider the use of multiple 
Gabor filters across one spectra, but that work for the future and it will require a 
more iterative approach in order to determine which filter is the most successful 
for each data point in the spectra.  Since we have determined that the 
variance/frequency combination of 10/10 has produced the best results across the 
three data sets, looking at the values in Table 10 reinforces the notion that the 
proposed algorithm is capable of predicting ovarian and control samples with a 
rate of greater than 95%. 
 The final evaluation of any algorithm is to compare it with any previous 
techniques to see if any improvement has been made.  The CA125 has been the 
best known serum marker for ovarian cancer and has been studied for many years.  
By analyzing the levels of CA125 in the sample, the test is only able to detect 
ovarian at a rate of about 40% to 50%.  In the last five years, scientists have been 
using a “..statistical model [that] converts the longitudinal CA125 profile to a 
single number called „risk of ovarian cancer‟, which is the risk of having the 
disease at a given time (Unknown 2002).”  This modified cA125 test recorded 
better results, but it was still only able to increase the sensitivity to a value 
between 70% and 85% while maintaining the specificity.  (Yasui 2003) used a 
boosting algorithm that only produced sensitivity  and specificity rates between 
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73% and 86%.  This is an improvement over the CA125 test, but still does not 
reach the levels needed to prevent false test results.  In contrast to the two 
previous examples, (Lilien 2003) was able to achieve sensitivity and specificity 
rates of above 97% using principal component analysis followed by linear 
discriminant analysis.  The downside to this algorithm is that it is more 
computationally intensive and complex than our proposed algorithm.  They 
showed that their training run time was O(n
3 
+ n
2 
r) and the testing runtime was 
O(mrn), which equates to about one to one and half minutes on a Pentium™ 4 
workstation.   
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Chapter Six: Conclusion 
Detecting the ovarian cancer in its early stages gives the patient a much 
higher five year survival rate, which has given rise to a need to find an efficient 
and an effective early detection mechanism for ovarian cancer. There are three 
existing methods that are used today to screen for ovarian cancer: Pelvic/rectal 
examination, ultrasound and the CA-125 blood test.  These tests are not 
consistently reliable, or accurate in screening for ovarian cancer, and they are very 
poor in determining ovarian cancer in the early stages of the disease.   Although 
scientists have discovered two genes, BRCA1 (Breast Cancer 1) and BRCA2 
(Breast Cancer 2), that greatly increase a woman’s chances of developing ovarian 
cancer, most BioInformaticists are using proteomic data to determine the presence 
of ovarian cancer. 
Based upon the criteria for a mass spectrometry classification algorithm, our 
proposed algorithm has the following characteristics: partial spectra, manually 
preprocessed, complex fragment mixtures, exact classification and used a multiple 
leave-out experiment for classification.  Following the examples of (Petricoin 
2002) and (Yasui 2003), we only a portion of the entire mass spectra data, and in 
particular, we used m/z values of 500 to 11,000.  Below the m/z value of 500, the 
energy absorbing molecules that attach to the desired proteins on the protein chip 
distort the data.  On the other end of the spectra, the m/z values above 11,000 had 
very minimal intensities that did not produce any features for the data set that 
made a difference to the final results.  This data was normalized between zero and 
one and was also smoothed to ensure that there were no discrepancies.  As 
 35 
explained above, our algorithm is considered an exact classification technique, 
which is capable of producing the same solution and is noniterative.  Finally, the 
data was split into three training/testing sets to ensure that the algorithm did not 
fall into the overfitting trap. 
Limitations 
Due to the limitations of the knowledge of the data set, we are not able to 
discern whether or not all or some of the ovarian cancer samples were from 
women in Stage I of the disease.  If the samples turn out to be from women who 
are in the latter stages of ovarian cancer, then it will be necessary to acquire a 
known ovarian cancer data set where the number of women in each stage is 
known.  This will allow us the ability to measure the effectiveness of the 
algorithm at different stages of the disease, and whether the algorithm is able to 
predict the disease at such a high level for Stage I cancer patients.   
As the number of false positives increases, the effectiveness of the 
algorithm decreases.  This is a limitation of all of the MSCAs, because none of 
them can predict with 100% sensitivity and specificity, so a number of the patients 
will be told that they have ovarian cancer when in fact they do not have it.  Also, a 
number of patients will be told that they do not have ovarian cancer when they do 
have the disease.  This becomes more evident when you start talking about a 
population of women in the tens of millions.  If your sensitivity rate is as high as 
95%, for every 10 million women tested, 500,000 women will result in a false 
positive. 
Future Research 
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Using one Gabor filter for the entire proteomic spectra may not have 
produced the highest level of results for effectively predicting ovarian and control 
patients.  The data sets could be analyzed using multiple Gabor filters across the 
entire spectrum. How will this be accomplished?  Each of the variance/frequency 
values used in our research can be used as input to create all of the Gabor filters.  
After the filters have been created, they will be applies one at a time on each data 
point.  This would be repeated for the entire spectrum, so that the confusion 
matrix values could be calculated. 
In addition to the use of multiple Gabor filters on one spectra, the algorithm 
discussed in this paper could be applied to different types of cancer (lung, 
prostrate, etc) to see if it able to produce similar results. 
Summary 
Our coded pattern algorithm produced highly successful results for determining 
whether a given sample was positive for ovarian cancer. A risk of analyzing high 
dimensionality data is creating a model that is overfitting for a particular data set.  
To prevent the overfitting, we split our data set into three training and testing sets 
to cross-validated our algorithm.  The algorithm was able to predict cancer and 
control with a sensitivity and specificity of above 95%, which is in contrast to the 
CA125 test that is only able to predict ovarian cancer at a rate of 40% to 50% This 
not only limited the affect of overfitting, but also allowed us to see if our 
algorithm could be used with different types of cancer data.  As discussed in the 
results section, our algorithm provided very similar results in both passes of the 
cancer/non-cancer data set.  It is our hope that we can use our algorithm with 
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different types of cancer data to provide a mechanism that medical professionals 
can use to diagnose cancer in its earliest stages. 
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APPENDICES 
Appendix A 
Excel™ Extraction Script 
 
%% This file will extract the intensity values from a set of Excel files 
 
fid=fopen('control_testing.txt','r');   % Needs to be your *.name file 
fout=fopen('control_test.data','w');  % Needs to be your *.data file  
 
while 1 
    new=fgetl(fid); 
 if ~isstr(new),break,end 
    temp=csvread(new,1,0); 
    [rows,cols] = size(temp); 
    for z=1:rows 
   for q=1:cols 
  if ((temp(z,1) >500) && (temp(z,1) <11000)) 
          fprintf(fout,'%10.6f,',temp(z,2)); 
  end 
   end    
    end 
    fprintf(fout,'\n'); 
 
    fprintf('%s\n', new); 
 
end 
fprintf('Done\n'); 
fclose all; 
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Appendix B 
Process/Analysis Script 
 
% This file will take the input cancer and control data and use a Gabor 
% filter using only one phase of the filter.  The data will then be 
% measured using the Hamming distance to determine the classification of 
% the cancer versus the non-cancer testing data. 
clear all; 
 
 
%% Init the parameters for the Gabor function and coded threshold 
threshold = 0.85; 
s_value   = 10; 
w_value   = 5; 
fsize    = 3*s_value; 
 
 
%%%% Create the output file 
fid = fopen('confusion_matrix__.txt','w'); 
fid1 = fopen('count.txt','w'); 
 
 
fprintf('\n'); 
fprintf('The time and date is %s\n',datestr(now)); 
fprintf('\n'); 
 
%%% Add note for which pass in the confusion_matrix.txt file 
fprintf(fid,'Third Data Set\n'); 
fprintf(fid,'\n'); 
fprintf(fid,'Threshold value: %4.2f\n',threshold); 
fprintf(fid,'S value: %d,  W value: %d, F_Size: %d\n',s_value,w_value,fsize); 
 
 
%%%%%%%%%%%%%%%%%%%%% 
% Read in the data for the first pass  %%% 
%%%%%%%%%%%%%%%%%%%%% 
fprintf('Reading in the training control data....\n'); 
control_train = load ('C:\Documents and Settings\Stuart Morton\My 
Documents\School\I692\Data\Second Set\control_train.data'); 
[contrain_row,contrain_col] = size(control_train); 
 
fprintf('Reading in the training cancer data....\n'); 
cancer_train  = load ('C:\Documents and Settings\Stuart Morton\My 
Documents\School\I692\Data\Second Set\ovarian_train.data'); 
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[cantrain_row,cantrain_col] = size(cancer_train); 
 
fprintf('Reading in the testing control data....\n'); 
control_test = load ('C:\Documents and Settings\Stuart Morton\My 
Documents\School\I692\Data\Second Set\control_test.data'); 
[contest_row,contest_col] = size(control_test); 
 
 
fprintf('Reading in the testing cancer data....\n'); 
cancer_test  = load ('C:\Documents and Settings\Stuart Morton\My 
Documents\School\I692\Data\Second Set\ovarian_test.data'); 
[cantest_row,cantest_col] = size(cancer_test); 
 
 
%%%%%%%%%%%%%%% 
%% Pre-process the data:  %% 
%%          %% 
%% 1) Baseline        %% 
%% 2) Smooth        %% 
%%          %% 
%%%%%%%%%%%%%%% 
fprintf('Preprocessing the data....\n'); 
 
fprintf('Baselining the training data....\n'); 
control_train = prepbaseline(control_train,'min',128);  
cancer_train = prepbaseline(cancer_train,'min',128);  
 
fprintf('Smoothing the training data....\n'); 
control_train = prepsmooth(control_train, 128); 
cancer_train = prepsmooth(cancer_train, 128); 
 
 
fprintf('Baselining the testing data....\n'); 
control_test = prepbaseline(control_test,'min',128);  
cancer_test = prepbaseline(cancer_test,'min',128);  
 
fprintf('Smoothing the testing data....\n'); 
control_test = prepsmooth(control_test, 128); 
cancer_test = prepsmooth(cancer_test, 128); 
 
 
%%%%%%%%%%%%%%%%%%% 
%% Create and apply Gabor filter %% 
%%%%%%%%%%%%%%%%%%% 
 
fprintf('Using a threshold value of %f\n',threshold); 
 
 44 
%%%%%%%%%%% Training Data %%%%%%%%%%% 
 
%%% Control train %%% 
final_controltrain = zeros(contrain_row,(contrain_col-(2*fsize))); 
size(final_controltrain); 
 
%%% Cancer train  %%% 
final_cancertrain = zeros(cantrain_row,(cantrain_col-(2*fsize))); 
size(final_cancertrain); 
 
 
%%% Temp matrix %%% 
temp = zeros(1,contrain_col); 
 
fprintf('Running the Gabor Filter with s=%d, w=%d, fsize=%d on train 
data....\n',s_value,w_value,fsize); 
 
 
for (i=1:contrain_row) 
 temp = control_train(i,:); 
 [Response,filter] = prepgaborfilter(temp,s_value,w_value,fsize); 
 final_controltrain(i,:) = Response; 
end 
 
%%%% Determine size of final_controltrain 
[controltrain_row,controltrain_col] = size(final_controltrain); 
 
 
%%% Temp matrix  %%% 
temp = zeros(1,cantrain_col); 
 
for (i=1:cantrain_row) 
 temp = cancer_train(i,:); 
 [Response,filter] = prepgaborfilter(temp,s_value,w_value,fsize); 
 final_cancertrain(i,:) = Response; 
end 
 
 
%%%% Determine size of final_cancertrain 
[cancertrain_row,cancertrain_col] = size(final_cancertrain); 
 
 
%%%%%%%% Testing Data %%%%%%%%% 
 
%%% Control test %%% 
%%% Need to size the final_controltest matrix to fit the  
%%% matrix that is calculated by the prepgaborfilter,  
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%%% which reduces the column size by 2*fsize 
 
final_controltest = zeros(contest_row,(contest_col-(2*fsize))); 
size(final_controltest); 
 
%%% Cancer train 
%%% Need to size the final_cancertest matrix to fit the matrix  
%%% that is calculated by the prepgaborfilter, which reduces the  
%%% column size by 2*fsize 
 
final_cancertest = zeros(cantest_row,(cantest_col-(2*fsize))); 
size(final_cancertest); 
 
 
%%% Temp matrix 
temp = zeros(1,contest_col); 
 
fprintf('Running the Gabor Filter with s=%d, w=%d, fsize=%d on test 
data....\n',s_value,w_value,fsize); 
 
 
for (i=1:contest_row) 
 temp = control_test(i,:); 
 [Response,filter] = prepgaborfilter(temp,s_value,w_value,fsize); 
 final_controltest(i,:) = Response; 
end 
 
%%%% Determine size of final_controltest 
[controltest_row,controltest_col] = size(final_controltest); 
 
 
%%% Temp matrix 
temp = zeros(1,cantest_col); 
 
for (i=1:cantest_row) 
 temp = cancer_test(i,:); 
 [Response,filter] = prepgaborfilter(temp,s_value,w_value,fsize); 
 final_cancertest(i,:) = Response; 
end 
 
 
%%%% Determine size of final_cancertest 
[cancertest_row,cancertest_col] = size(final_cancertest); 
 
 
 
%%%%%%%%%% %%%%%%%%%%%%%%%%% 
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%% Determine the code for each entry in the matrix %% 
%%%%%%%%%%%%%%%%%%%%%%%%%%% 
 
 
%%%%%%%%%%%% Control Training %%%%%%%%%%% 
 
fprintf('Determine the code for the control training set... \n'); 
 
code_controltrain = zeros(controltrain_row,controltrain_col*2); 
 
 
current = 1; 
 
temp = 0; 
 
for (i = 1:controltrain_row) 
 for (j = 1:controltrain_col) 
 
  %%% Testing for 1st entry 
  temp = j; 
 
  if (j == 1) 
   current = hardlim(real(final_controltrain(i,j))); 
   current = cat(2, current, 
hardlim(imag(final_controltrain(i,j))));  
 
  else 
   current = cat(2, current, 
hardlim(real(final_controltrain(i,j)))); 
   current = cat(2, current, 
hardlim(imag(final_controltrain(i,j))));  
  end 
 
 end 
 
 %%% Set the value into the code_controltrain(i,temp) 
 code_controltrain(i,:) = current; 
end 
 
 
%%%%% Determine the pattern for the control group,  
%%%%% using a X% threshold as the criteria for either 
%%%%% a zero or a one.  If the total is not greater  
%%%%% than/equal to the threshold, then the value is nine 
 
control_total = zeros(1,controltrain_col*2); 
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for (col = 1:controltrain_col*2) 
 
 %% init the counts 
 zero_count = 0; 
 one_count  = 0; 
 
 for (row = 1: controltrain_row) 
  if (code_controltrain(row,col) == 0) 
   zero_count = zero_count + 1; 
  else 
   one_count  = one_count + 1; 
  end  
 end 
 
 %fprintf(fid1,'Column:%d  zero:%d   one:%d \n',col,zero_count, 
one_count); 
 
 
 %%%%%%% Determine the value for the column 
 if ((zero_count/controltrain_row) >= threshold) 
  control_total(1,col) = 0; 
 elseif ((one_count/controltrain_row) >= threshold) 
  control_total(1,col) = 1; 
 else 
  control_total(1,col) = 9; 
 end 
 
end 
 
%%%%%%%%%%%% Cancer Training %%%%%%%%%%%%%%% 
fprintf('Determine the code for the cancer training set.... \n'); 
 
code_cancertrain = zeros(cancertrain_row,cancertrain_col*2); 
 
 
current = 1; 
 
temp = 0; 
 
for (i = 1:cancertrain_row) 
 for (j = 1:cancertrain_col) 
 
  %%% Testing for 1st entry 
  temp = j; 
 
  if (j == 1) 
   current = hardlim(real(final_cancertrain(i,j))); 
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   current = cat(2, current, 
hardlim(imag(final_cancertrain(i,j))));  
 
  else 
   current = cat(2, current, 
hardlim(real(final_cancertrain(i,j)))); 
   current = cat(2, current, 
hardlim(imag(final_cancertrain(i,j))));  
  end 
 
 end 
 
 %%% Set the value into the code_cancertrain(i,temp) 
 code_cancertrain(i,:) = current; 
end 
 
%%%%% Determine the pattern for the control group,  
%%%%% using a X% threshold as the criteria for either 
%%%%% a zero or a one.  If the total is not greater  
%%%%% than/equal to the threshold, then the value is nine 
 
cancer_total = zeros(1,cancertrain_col*2); 
 
for (col = 1:cancertrain_col*2) 
 
 %% init the counts 
 zero_count = 0; 
 one_count  = 0; 
 
 for (row = 1: cancertrain_row) 
  if (code_cancertrain(row,col) == 0) 
   zero_count = zero_count + 1; 
  else 
   one_count  = one_count + 1; 
  end  
 end 
 
 %fprintf(fid1,'Column:%d  zero:%d   one:%d \n',col,zero_count, 
one_count); 
 
 
 %%%%%%% Determine the value for the column 
 if ((zero_count/cancertrain_row) >= threshold) 
  cancer_total(1,col) = 0; 
 elseif ((one_count/cancertrain_row) >= threshold) 
  cancer_total(1,col) = 1; 
 else 
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  cancer_total(1,col) = 9; 
 end 
 
end 
 
 
%%%%%%%%%%%% Control Testing %%%%%%%%%%%%%% 
fprintf('Determine the code for the control testing set.... \n'); 
 
code_controltest = zeros(controltest_row,controltrain_col*2); 
 
 
current = 1; 
 
temp = 0; 
 
for (i = 1:controltest_row) 
 for (j = 1:controltest_col) 
 
  %%% Testing for 1st entry 
  temp = j; 
 
  if (j == 1) 
   current = hardlim(real(final_controltest(i,j))); 
   current = cat(2, current, 
hardlim(imag(final_controltest(i,j))));  
 
  else 
   current = cat(2, current, 
hardlim(real(final_controltest(i,j)))); 
   current = cat(2, current, 
hardlim(imag(final_controltest(i,j))));  
  end 
 
 end 
 
 %%% Set the value into the code_controltest(i,temp) 
 code_controltest(i,:) = current; 
end 
 
%%%%%%%%%%%% Cancer Testing %%%%%%%%%%%%%%% 
 
fprintf('Determine the code for the cancer testing set.... \n'); 
 
code_cancertest = zeros(cancertest_row,cancertest_col*2); 
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current = 1; 
 
temp = 0; 
 
for (i = 1:cancertest_row) 
 for (j = 1:cancertest_col) 
 
  %%% Testing for 1st entry 
  temp = j; 
 
  if (j == 1) 
   current = hardlim(real(final_cancertest(i,j))); 
   current = cat(2, current, 
hardlim(imag(final_cancertest(i,j))));  
 
  else 
   current = cat(2, current, hardlim(real(final_cancertest(i,j)))); 
   current = cat(2, current, 
hardlim(imag(final_cancertest(i,j))));  
  end 
 
 end 
 
 %%% Set the value into the code_cancertest(i,temp) 
 code_cancertest(i,:) = current; 
end 
 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%%%%%%%%%%%% Calculate the Hamming Distance %%%%%%%%%%% 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
 
 
fprintf('Calculating the Hamming Distance.... \n'); 
 
 
%%% Compare the Control training versus the Control testing 
hd_control_control = zeros(controltest_row,1); 
 
for (i = 1:controltest_row) 
 
 %% Init the Hamming distance variables to be zero 
 hd_controltest1 = 0; 
 %nine_count1 = 0; 
 
 for (j = 1:controltest_col*2) 
  if (control_total(1,j) == 9) 
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 %      nine_count1 = nine_count1 + 1;  
  else 
   if (control_total(1,j) ~= code_controltest(i,j)) 
    hd_controltest1 = hd_controltest1 + 1; 
   end 
  end 
 end 
 
 % Set the value to the hd_control_control 
        hd_control_control(i,1) = hd_controltest1; 
 
 fprintf(fid1,'Control testing/Control training %d:  %d\n',i,hd_controltest1); 
end 
 
 
%%% Compare the Control training versus the Cancer testing 
hd_control_cancer = zeros(controltest_row,1); 
 
for (i = 1:controltest_row) 
 
 %% Init the Hamming distance variables to be zero 
 hd_controltest2 = 0; 
 %nine_count2 = 0; 
 
 for (j = 1:controltest_col*2) 
  if (cancer_total(1,j) == 9) 
 %      nine_count2 = nine_count2 + 1;  
  else 
   if (cancer_total(1,j) ~= code_controltest(i,j)) 
    hd_controltest2 = hd_controltest2 + 1; 
   end 
  end 
 end 
 
  
 % Set the value to the hd_control_cancer 
        hd_control_cancer(i,1) = hd_controltest2; 
 
 fprintf(fid1,'Control testing/Cancer training %d:  %d\n',i,hd_controltest2); 
end 
 
 
%%% Compare the Cancer training versus the Control testing 
hd_cancer_control = zeros(cancertest_row,1); 
 
for (i = 1:cancertest_row) 
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 %% Init the Hamming distance variables to be zero 
 hd_cancertest1 = 0; 
 %nine_count3 = 0; 
 
 for (j = 1:cancertest_col*2) 
  if (control_total(1,j) == 9) 
 %      nine_count3 = nine_count3 + 1;  
  else 
   if (control_total(1,j) ~= code_cancertest(i,j)) 
    hd_cancertest1 = hd_cancertest1 + 1; 
   end 
  end 
 end 
 
 % Set the value to the hd_cancer_control 
        hd_cancer_control(i,1) = hd_cancertest1; 
 
 fprintf(fid1,'Cancer testing/Control training %d:  %d\n', i,hd_cancertest1); 
end 
 
 
%%% Compare the Cancer training versus the Cancer testing  %%% 
 
hd_cancer_cancer = zeros(cancertest_row,1); 
 
for (i = 1:cancertest_row) 
 
 %% Init the Hamming distance variables to be zero 
 hd_cancertest2 = 0; 
 %nine_count4 = 0; 
 
 for (j = 1:cancertest_col*2) 
  if (cancer_total(1,j) == 9) 
 %      nine_count4 = nine_count4 + 1;  
  else 
   if (cancer_total(1,j) ~= code_cancertest(i,j)) 
    hd_cancertest2 = hd_cancertest2 + 1; 
   end 
  end 
 end 
 
 % Set the value to the hd_cancer_control 
        hd_cancer_cancer(i,1) = hd_cancertest2; 
  
 fprintf(fid1,'Cancer testing/Cancer training %d:  %d\n', i,hd_cancertest2); 
end 
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tn = 0; 
fn = 0; 
tp = 0; 
fp = 0; 
 
fprintf('Calculate the confusion matrix.... \n'); 
 
for (k=1:controltest_row) 
 if (hd_control_control(k,1) < hd_control_cancer(k,1)) 
  tn = tn + 1; 
 else 
  fn = fn + 1; 
 end 
end 
 
for (k=1:cancertest_row) 
 if (hd_cancer_cancer(k,1) < hd_cancer_control(k,1)) 
  tp = tp + 1; 
 else 
  fp = fp + 1; 
 end 
end 
 
%% Print the confusion matrix 
fprintf(fid,'tn: %d\n',tn); 
fprintf(fid,'fn: %d\n',fn); 
fprintf(fid,'tp: %d\n',tp); 
fprintf(fid,'fp: %d\n',fp); 
 
fprintf(fid,'\n'); 
fprintf(fid,'Sensitivity: %4.2f\n',tp/(tp+fn)); 
fprintf(fid,'Specificity: %4.2f\n',tn/(tn+fp)); 
fprintf(fid,'Accuracy: %4.2f\n',(tn+tp)/(tp+tn+fp+fn)); 
 
fprintf('\n'); 
fprintf('\n'); 
fprintf('Sensitivity: %4.2f\n',tp/(tp+fn)); 
fprintf('Specificity: %4.2f\n',tn/(tn+fp)); 
fprintf('Accuracy: %4.2f\n',(tn+tp)/(tp+tn+fp+fn)); 
 
fprintf('The time and date is %s\n',datestr(now)); 
 
fprintf('Done.... \n'); 
 
%%%% Close the file 
fclose(fid); 
fclose(fid1);
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Stuart M. Morton 
 
4366 Greenthread Drive 
Zionsville, IN  46077 
Tel: (317) 769-2500 
Email: smorton22@tds.net  
 
WORK EXPERIENCE: 
 
Covance Inc, Indianapolis, IN. 2005 – 2006 
 
Project Details: 
 
Java Developer:     August 2005 – August 2006 
 
Developed applications for the Covance Central Labs that allows customers to 
create, maintain and retrieve results of clinical trials. 
 
As a Senior Java Developer, my responsibilities included: 
 
 Creating web-based and GUI applications using Java J2EE, C# and JTML 
 Providing technical support for the Covance clinical trial sites 
 Developing software to allow Covance the ability to data mine clinical 
trial information 
 
As a Database Administrator: 
 
 Maintained the clinical trial database 
 Provided data support for Covance clinical trial kits 
 
 Software: J2EE, JHTML, C#, Microsoft SourceSafe, JSP, HTML, Perl 
Operating System: UNIX, Windows 2000 and XP 
 
Lucent Technologies, Naperville, IL. 1997 – 2005 
 
Project Details: 
 
Packet Core DB Developer:     Jan 2001 – July 2005 
 
The Packet Core project allows a customer the ability to utilize secure Internet 
connections to route cellular data calls rather than using local carriers, and thus 
reducing their costs.   
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As a Senior Java Developer/Architect, my responsibilities included: 
 
 Creating Java based software, Dynamic Update Agent that allows dynamic 
data to be sent to customer‟s equipment without the need to reboot the 
equipment in order to read the new DB values. 
 Providing updates to the DUA when the customer requests new dynamic 
data to be added to their system 
 Developing thread monitoring for Java processes that has a patent pending 
 Unit testing of the Dynamic Update Agent 
 Creating Java based DB backup and restore software that allows a 
customer to backup and restore their configuration data for disaster 
recovery. 
 Responsible for the software architecture of the DB system for the Packet 
Core project 
 
 Developing and maintaining an SQL based DB that allows a customer to 
provision their Packet Core equipment via a web based provisioning 
interface 
 Unit testing  of the DB 
 Providing scripts to populate the DB for lab testing by other development 
teams 
 Training classes for developers in China who will take ownership of the 
Packet Core DB system 
 DB lab support for other development teams 
 
Software:  C/C++, JNI, J2SE, JDBC, CCMS, Apache Web Server, JSP, 
HTML, JavaScript, Perl 
Operating System: UNIX, Windows 2000 
 
ECP TDMA Edge DB Developer:    Feb 2000 – Dec 2000 
 
The TDMA cellular system utilizes a time division algorithm to allow multiple 
cell phone users to use the same radio channel, but in different time allocations.  
EDGE is an enhanced data rate for cellular phones that use the Global System for 
Mobile Communications (GSM) 
 
As a SQL/XML Developer, my responsibilities included: 
 
 Developing a prototype database system that utilized XML to generate 
SQL that would be used by the customer to provision their TDMA system 
 Creating scripts to simulate DB creation, DB field population and failure 
scenarios 
 Testing the prototype DBMS in a cellular lab environment 
 Writing customer documentation  
 
Software: SQL, XML, XML Schema, DTD, HTML 
Operating System: UNIX, Windows 2000 
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ECP CDMA DB Designer:     Jul 1997  - Jan 2000 
 
The ECP is the Executive Cellular Processor that is responsible for processing 
cellular telephone calls, billing and performance monitoring of a cellular 
customer‟s wireless telephone equipment.  The provisioning system used a text 
based menu system that stored the data in a link list database.  CDMA is a cellular 
technology that utilizes a spread spectrum form of modulation requiring a 
contiguous block of spectrum (1.25 MHz) rather than channels as used by analog 
of TDMA telephones. 
  
As a team leader of five C database developers, my responsibilities included: 
 
 Taking the data requirements from the customer and creating a design 
document , and then assigning the developer‟s their piece of the 
development 
 Implementing the data design to provide the customer a text based 
interface that allows them to provision their cellular equipment and have it 
stored in a database that is accessed using C structures. 
 Testing of the code in a cellular lab environment 
 Providing support of the provisioning system at the customer‟s site 
 Generating weekly status reports on the status of the DB development 
 Maintaining the group and department web pages 
 Leading a Quality Improvement team to develop a standardized Data 
System Requirements document template.  The plan was to reduce the 
interval and provide consistent data requirements across projects 
 Co-wrote the online Database Process, which involved working with 
multiple sources including the Design and Code Process Management 
team, the Data Subsystem owners and the Data developers. 
 
 
Software: C,  HTML, Perl, Java, JavaScript, Word, Excel, PowerPoint, 
Change Management System 
Operating System :  UNIX, Windows NT, 2000 
 
 Current role involves managing a team of 7 developers on Lucent‟s Internet 
Protocol project, while also developing, testing and integrating Java code for 
the same project that will be used to dynamically update data on customer‟s 
telephone equipment. 
 Created and presented a remote testing class for Lucent employees that 
demonstrates the ability to test and develop software from any remote 
location. 
 
Purdue University Department of Computer Science at Indianapolis, IN. 
1994 - 1997 
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 Research Assistant – Research involved transaction management in distributed 
medical database systems. * 
 Teaching Assistant – Instructor for two Internet development classes and a 
Pascal programming class. 
 
Eli Lilly and Company, Research Laboratories, Indianapolis, IN. Summer 
1990 
 Worked as an analyst in the Department of Chemistry.   
 
 
EDUCATION: 
 
PhD Bioinformatics         
Started program August 2006       
Indiana University                   
Indianapolis, IN  46202      
         
M. S.  Bioinformatics 
Projected Graduation September 2006  
Indiana University 
Indianapolis, IN  46202 
Grade Point Average: 4.0/4.0 
 
Masters Thesis, Indiana University (Jan 2005-Sept 2006): 
 “Gabor Wavelet Phase Quantization and Binary Coding for Ovarian Cancer 
Serum Protein Profiling” (Submitted to SAC2007) 
o Analyzed proteomic ovarian spectra generated by Mass Spectrometry 
instruments 
o Utilized Gabor filters for detecting optimal localizations in the spectra 
o Proposed a binary coding scheme to classify ovarian and non-ovarian 
samples 
 
 
 
M. S.  Computer Science, August 1997   
Purdue University       
Indianapolis, IN  46202     
Grade Point Average: 3.6/4.0    
 
PUBLICATIONS (Available at http://home.indy.rr.com/smorton/abstr.html) 
 
 S. Morton, O. Bukhres, E. Vanderdijs, P. Zhang, M. Mossman, C. Crawley, J. 
Platt. “A Proposed Mobile Architecture for a Distributed Database 
Environment” Proceedings of the 5th Euromicro Workshop on Parallel and 
Distributed Processing, 1997. 
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 S. Morton, O. Bukhres. “Utilizing Mobile Computing in the Wishard 
Memorial Hospital Ambulatory Service” Proceedings of the 12th ACM 
Symposium on Applied Computing (ACM SAC 1997). S. Morton, O. Bukhres. 
“Mobile Transaction Management in Distributed Medical Databases” 
Proceedings of the 10
th
 IEEE Symposium on Computer-Based Medical 
Systems (CBMS 1997). 
 S. Morton, O. Bukhres, M. Mossman. “Mobile Computing Architecture for a 
Battlefield Environment” Proceedings of the International Symposium on 
Cooperative Database Systems for Advanced Applications, 1996. 
 S. Morton, O. Bukhres. “Mobile Transaction Recovery in Distributed Medical 
Databases”  Proceedings of the IASTED Eighth International Conference on 
Parallel and Distributed Computing and Systems, 1996. 
 
 
ADDITIONAL UNIVERSITY CLASSES: 
Indiana University at Indianapolis (1994):  
 Graduate: Immunology  
 Undergraduate: Introduction to Microbiology, Cell Biology, Computer 
Applications in Biology and Medicine, Genetics & Molecular Biology, 
Introduction Java Programming 
 
B. A.  Computer Science, May 1993     
Pre-Med program                     
DePauw University 
Greencastle, IN  46135 
Grade Point Average: 3.25/4.0  
   
 
RELEVANT COMPUTER SKILLS (1993- 2006): 
 Programming Languages: C, C++, Java, C#, JNI, HTML, UML, XML, 
SQL, Perl   
 Operating Systems: UNIX, Windows, Mac 
 Other Applications: MS Office, Netscape, Internet Explorer, Latex, 
MATLAB 
 
 
 
 
